Panacea files patent for its immune system enhancing immunotherapy

Panacea focuses on unmet clinical and medical needs. | File photo

Panacea Pharmaceuticals has filed a U.S. patent application for Immune System Enhancing Immunotherapy for the treatment of cancer.

Founded in 1999, Panacea focuses on unmet clinical and medical needs and attempts to fill those needs with innovative, breakthrough solutions. The company specifically discovers, develops and commercializes innovative therapeutic and diagnostic products for cancer and diseases of the central nervous system. 

Panacea is headquartered in the 270 Biotechnology Corridor in Maryland.

Want to get notified whenever we write about Panacea Pharmaceuticals ?
Next time we write about Panacea Pharmaceuticals, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.
Organizations in this story

Panacea Pharmaceuticals 209 Perry Pkwy Gaithersburg, MD 20877